Review Articles /
November 2026
BC Cancer estimates the average-risk patient’s lifetime risk of pancreas ductal adenocarcinoma at 1.3%. In contrast, pancreatic neuroendocrine tumors (NETs) are rare. The pancreatic NET incidence was less than 1 case... Read More